ST7L (suppression of tumorigenicity 7 like)

2003-02-01  

Identity

HGNC
LOCATION
1p13.2
LOCUSID
ALIAS
FAM4B,ST7R,STLR
FUSION GENES

Other Information

Locus ID:

NCBI: 54879
MIM: 617640
HGNC: 18441
Ensembl: ENSG00000007341

Variants:

dbSNP: 54879
ClinVar: 54879
TCGA: ENSG00000007341
COSMIC: ST7L

RNA/Proteins

Gene IDTranscript IDUniprot
ENSG00000007341ENST00000343210Q8TDW4
ENSG00000007341ENST00000358039Q8TDW4
ENSG00000007341ENST00000360743Q8TDW4
ENSG00000007341ENST00000361846Q8TDW4
ENSG00000007341ENST00000369664Q5TEH7
ENSG00000007341ENST00000369666Q8TDW4
ENSG00000007341ENST00000369669Q8TDW4
ENSG00000007341ENST00000418497H0Y7M0
ENSG00000007341ENST00000490067Q8TDW4
ENSG00000007341ENST00000490715Q8TDW4

Expression (GTEx)

0
5
10
15
20
25

Protein levels (Protein atlas)

Not detected
Low
Medium
High

References

Pubmed IDYearTitleCitations
231422182013MiR-24 regulates the proliferation and invasion of glioma by ST7L via β-catenin/Tcf-4 signaling.25
275373902016miR-23a promotes IKKα expression but suppresses ST7L expression to contribute to the malignancy of epithelial ovarian cancer cells.15
289023562017miR-378 functions as an onco-miRNA by targeting the ST7L/Wnt/β-catenin pathway in cervical cancer.13
301769332018Long noncoding RNA MIR31HG inhibits hepatocellular carcinoma proliferation and metastasis by sponging microRNA-575 to modulate ST7L expression.13
285181442017MicroRNA-23b functions as an oncogene and activates AKT/GSK3β/β-catenin signaling by targeting ST7L in hepatocellular carcinoma.11
298507662018miR-331-3p functions as an oncogene by targeting ST7L in pancreatic cancer.10

Citation

Dessen P

ST7L (suppression of tumorigenicity 7 like)

Atlas Genet Cytogenet Oncol Haematol. 2003-02-01

Online version: http://atlasgeneticsoncology.org/gene/42425/st7l